BBarclays MMarvell · MRVL

Barclays Upgrades Marvell to Overweight

Apr 9, 2026· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$150
Previous
$105
Implied upside
+31%

Barclays analyst Tom O’Malley upgraded Marvell Technology (NASDAQ: MRVL) from Equalweight to Overweight with a price target of $150.00 (from $105.00).

“The last few months of 2025 saw the stock weighed down by narratives surrounding Trainium share loss and issues with 1.6T DSPs (see our downgrade).

The major change since the DG is that industry checks suggest Optical ports should double in 2026 and double again in 2027.

Our math implies that Optical could grow ~90% for MRVL this year and next, even with some share shift to AVGO.

We lay out a scenario below that shows that even when eliminating MSFT entirely, no unit growth at AMZN, and discounting XPU attach we still get to ~$5 of earnings.

We don’t agree with those assumptions and in fact are more confident in MSFT ramping after the NVDANVLink Fusion announcement.

This story will come down to executing on a well understood and bullish forecast and we think the narrative is shifting more towards Optics where it belongs. Our PT moves to $150.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.